# Winnie W. Nelson

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/winnie-w-nelson/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,114 |
| Field | Atrial Fibrillation Management and Outcomes |
| h-index | 33 |
| i10-index | 81 |
| Last Known Institution | Helsinn Therapeutics (United States) |
| OpenAlex ID | https://openalex.org/A5077613669 |
| ORCID iD | 0000-0003-0013-3199 |
| Works | 150 |

## Researcher papers

- [Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review](https://scholariq.org/papers/long-term-systemic-corticosteroid-exposure-a-systematic-literature-review/)
- [Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF](https://scholariq.org/papers/cause-of-death-and-predictors-of-all-cause-mortality-in-anticoagulated-patients/)
- [Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients](https://scholariq.org/papers/real-world-comparative-effectiveness-and-safety-of-rivaroxaban-and-warfarin-in/)
- [Current practice patterns and patient persistence with anticoagulant treatments for cancer‐associated thrombosis](https://scholariq.org/papers/current-practice-patterns-and-patient-persistence-with-anticoagulant-treatments/)
- [Evaluation of US prescription patterns: Are treatment guidelines for cancer-associated venous thromboembolism being followed?](https://scholariq.org/papers/evaluation-of-us-prescription-patterns-are-treatment-guidelines-for-cancer/)
- [Impact of Daily Dosing Frequency on Adherence to Chronic Medications Among Nonvalvular Atrial Fibrillation Patients](https://scholariq.org/papers/impact-of-daily-dosing-frequency-on-adherence-to-chronic-medications-among/)
- [Medication errors involving patient-controlled analgesia](https://scholariq.org/papers/medication-errors-involving-patient-controlled-analgesia/)
- [Priorities Among Effective Clinical Preventive Services](https://scholariq.org/papers/priorities-among-effective-clinical-preventive-services/)
- [Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancer](https://scholariq.org/papers/effectiveness-and-safety-of-anticoagulants-for-the-treatment-of-venous/)
- [Effect of Increased Cost-Sharing on Oral Hypoglycemic Use in Five Managed Care Organizations](https://scholariq.org/papers/effect-of-increased-cost-sharing-on-oral-hypoglycemic-use-in-five-managed-care/)
- [<p>Treatment Patterns and Health Care Costs of Lupus Nephritis in a United States Payer Population</p>](https://scholariq.org/papers/and-lt-p-and-gt-treatment-patterns-and-health-care-costs-of-lupus-nephritis-in-a/)

## Researcher topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/)
- [Medication Adherence and Compliance](https://scholariq.org/topics/medication-adherence-and-compliance/)
- [Pharmaceutical Practices and Patient Outcomes](https://scholariq.org/topics/pharmaceutical-practices-and-patient-outcomes/)
- [Clostridium difficile and Clostridium perfringens research](https://scholariq.org/topics/clostridium-difficile-and-clostridium-perfringens-research/)

## Researcher university

- [Helsinn Therapeutics (United States)](https://scholariq.org/institutions/helsinn-therapeutics-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.